Pulmonary/Respiratory Medicine CME

Credits: 0.50 CME / MOC / NCPD
Medical Learning Institute, Inc.
Examining Novel Approaches to Improve the Management of Influenza: An Animated Exploration
July 21, 2021
Credits: 1.50 CME / MOC / CC / NCPD
Medical Learning Institute, Inc.
Tracking All the Targets in Genomically Altered NSCLC: Everything You Need to Know About Biomarker Testing and Treatment
July 6, 2021
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Making the Most of Treatment Advances in SCLC: New Standards, Practicalities of Care, and Hope on the Horizon
July 5, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
Advancing the Treatment of Pompe Disease: Clinical Updates in Newborn Screening and Enzyme Replacement
June 10, 2021
Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
An Animated Exploration of Chronic Fibrosing Interstitial Lung Disease: From Diagnosis to Management in the Era of Antifibrotic Therapy
May 25, 2021
Credits: 1.00 CME / MOC / CC
Medical Learning Institute, Inc.
Immunotherapy as a Game-Changer in Multimodal Management of Locally Advanced and Earlier Stages of Lung Cancer
May 21, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
The Evolving Role of Oxybate Agents in the Management of Narcolepsy: A Visual Exploration of Individualized Care
May 18, 2021
Credits: 0.50 CME / NCPD / CPE
Purdue University College of Pharmacy
Analyzing the Pros and Cons of Standard and Alternative Dosing Regimens of Immunotherapies and Combinations in Modern Oncology Practice
May 11, 2021
Credits: 1.50 CME / MOC / CC
Medical Learning Institute, Inc.
Revisiting PD-L1 as an Immunotherapy Biomarker Across the Cancer Spectrum: Current and Emerging Standards of Testing, Scoring, and Assay Interpretation
May 11, 2021
Credits: 1.00 CME
Medical Learning Institute, Inc.
The Importance of Early Recognition of Interstitial Lung Diseases: Practical Strategies for the Radiologist
May 10, 2021
Credits: 1.00 CME
Medical Learning Institute, Inc.
Applying Evidence to Practice: Updated Consensus Recommendations for the Diagnosis, Surveillance, and Management of Tuberous Sclerosis Complex
April 14, 2021
Credits: 1.00 CME / MOC / CC
Medical Learning Institute, Inc.
Precision Decisions in Genomic Testing and Targeted Treatment of NSCLC
April 13, 2021
Credits: 1.00 CME / MOC / CC
Medical Learning Institute, Inc.
HER2 and HER3 Alterations as Therapeutic Targets of Increasing Significance in Solid Tumors: Implications for Pathology and Oncology Practice
April 6, 2021
Credits: 1.00 CME / MOC / CC
Medical Learning Institute, Inc.
The Nuances of Immunotherapy Biomarker Testing in Solid Tumors: Unraveling Complexities and Overcoming Challenges to Improve Outcomes
April 5, 2021
Credits: 0.50 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
Targeting Hypoxia-Inducible Factor Stabilization as a Treatment for Anemia in Chronic Kidney Disease: Examining the Current State of the Science
March 26, 2021
Credits: 0.50 CME / MOC / CE
Medical Learning Institute, Inc.
Innovative Blood-Based Screening in Cancer Care: State of the Science and Future Opportunities for Accelerating Cancer Diagnoses
March 18, 2021
Credits: 0.50 ABO / CME / MOC
Medical Learning Institute, Inc.
A Quick Look at Recent Evidence for Improving Outcomes in Patients With Diabetic Retinopathy Using Anti-VEGF Therapy
February 25, 2021
Credits: 0.50 CME / MOC / NCPD
Medical Learning Institute, Inc.
Improving Adherence to Evidence-Based Guidelines for the Diagnosis and Management of COPD: Practical Strategies for the Healthcare Team to Optimize Patient Care
February 15, 2021
Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
Managing Bleeding Events in Patients Receiving Direct Oral Anticoagulants: When Is It Appropriate to Implement Reversal Strategies in Patients With GI Bleeding?
January 26, 2021
Credits: 1.00 CME / MOC / CC
Medical Learning Institute, Inc.
New Horizons in EGFR-Mutated NSCLC: Broadening the Impact of Precision Testing in the Context of an Expanding Treatment Landscape
January 26, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
MS Treatment Decisions Before, During, and After Pregnancy: Focus on the Use of Disease-Modifying Therapies
January 22, 2021
Credits: 0.25 CME
Medical Learning Institute, Inc.
Provider Perspectives on Current and Emerging Disease-Modifying Treatments for Multiple Sclerosis
December 31, 2020
Credits: 0.50 CME
Medical Learning Institute, Inc.
Improving Outcomes in ALS Through Early Diagnosis and Emerging Targeted Therapies
December 31, 2020
Credits: 1.50 CME
Medical Learning Institute, Inc.
Precision Medicine in Hematologic Cancers: Lessons for Diagnostic and Treatment Protocols in CD30- and CD123-Expressing Disease
December 31, 2020

Pages